Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.
<h4>Background and aims</h4>Liver fibrosis is a major cause of morbidity and mortality. It is characterised by excessive extracellular matrix (ECM) deposition from activated hepatic stellate cells (HSCs). Although potentially reversible, treatment remains limited. Understanding how ECM i...
Saved in:
| Main Authors: | James Pritchett, Varinder S Athwal, Emma Harvey, Katherine Martin, Jessica Llewellyn, Philip Ireland, Alexander Nicolaides, Martin J Humphries, Nicoletta Bobola, Neil A Hanley, Karen Piper Hanley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0100091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
by: Varinder S Athwal, et al.
Published: (2017-11-01) -
Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review
by: Christopher Mysko, et al.
Published: (2025-03-01) -
SOX9 plays an essential role in myofibroblast driven hepatic granuloma integrity and parenchymal repair during schistosomiasis-induced liver damage
by: Kim Su, et al.
Published: (2025-06-01) -
SOX9 plays an essential role in myofibroblast driven hepatic granuloma integrity and parenchymal repair during schistosomiasis-induced liver damage.
by: Kim Su, et al.
Published: (2025-06-01) -
Proof of concept pilot study to assess the utility of magnetic resonance extra-cellular volume quantification to diagnose advanced liver disease in people with Cystic Fibrosis.
by: Daniel H Tewkesbury, et al.
Published: (2025-01-01)